Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
A recent study published in the BMJ investigated the associations between coronavirus disease 2019 (COVID-19) vaccination or non-vaccination and adverse ...
Women are more than twice as likely to die after a heart attack than men, according to research presented today ...
In a recent study published in the JAMA Pediatrics Journal, researchers assessed changes in the severity and epidemiology of respiratory ...
An international research team, comprising scientists from DZNE, University Hospital Bonn, the Netherlands, and the US has been awarded a ...
Young women who experience a heart attack have more adverse outcomes and are more likely to end up back in ...
It took Samantha Lesmeister's family four months to find a medical professional who could see that she was struggling with ...
In a recent article published in the Infection Control & Hospital Epidemiology Journal, researchers conducted an observational cohort study among ...
*Important notice: Preprints with The Lancet / SSRN publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not ...
The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the...
Read moreNEWS RELEASE: MGS MFG. Group acquires Danish product design firm Technolution Members of Technolution and MGS Mfg. Group GERMANTOWN, Wis....
Read moreIn a recent study published in the Nutrients Journal, researchers explored the phytochemical contents and health benefits of consuming figs....
Read moreDeviceTalks Editorial Director Tom Salemi (left) interviewed Boston Scientific CEO Mike Mahoney (right) in front of a crowd of medtech...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.